SSRIs
This glossary item is used in the course Intellectual Property Online
SSRIs
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders. The exact mechanism of action of SSRIs is unknown. They are believed to increase the extracellular level of the neurotransmitter serotonin by limiting its reabsorption (reuptake) into the presynaptic cell, increasing the level of serotonin in the synaptic cleft available to bind to the postsynaptic receptor. They have varying degrees of selectivity for the other monoamine transporters, with pure SSRIs having only weak affinity for the norepinephrine and dopamine transporters.
Intellectual Property Online
Obtaining a patent is a crucial step to safeguard the intellectual property of a novel biomedical intervention and to raise funding for its development. This course discusses the pros and cons of intellectual property and the do’s and don’ts to protect your biomedical invention in a timely manner.